NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organization

Abstract Background The NSD2 p.E1099K (EK) mutation is shown to be enriched in patients with relapsed acute lymphoblastic leukemia (ALL), indicating a role in clonal evolution and drug resistance. Results To uncover 3D chromatin architecture-related mechanisms underlying drug resistance, we perform...

Full description

Bibliographic Details
Published in:	Genome Biology
Main Authors:	Sonali Narang, Nikki A. Evensen, Jason Saliba, Joanna Pierro, Mignon L. Loh, Patrick A. Brown, Pandurang Kolekar, Heather Mulder, Ying Shao, John Easton, Xiaotu Ma, Aristotelis Tsirigos, William L. Carroll
Format:	Article
Language:	English
Published:	BMC 2023-04-01
Subjects:	Relapsed acute lymphoblastic leukemia NSD2 Clonal evolution Chromatin architecture
Online Access:	https://doi.org/10.1186/s13059-023-02905-0

Similar Items

NSD proteins in anti-tumor immunity and their therapeutic targeting by protein degraders
by: Suresh Chava, et al.
Published: (2025-06-01)

Systematic perturbations of SETD2, NSD1, NSD2, NSD3, and ASH1L reveal their distinct contributions to H3K36 methylation
by: Gerry A. Shipman, et al.
Published: (2024-10-01)

NSD1: A Lysine Methyltransferase between Developmental Disorders and Cancer
by: Samantha Tauchmann, et al.
Published: (2021-08-01)

The first pineoblastoma case report of a patient with Sotos syndrome harboring NSD1 germline mutation
by: Xizan Yue, et al.
Published: (2024-03-01)

NSD1 in erythroid differentiation and leukemogenesis
by: Samantha Tauchmann, et al.
Published: (2020-11-01)

Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase
by: Philipp Rathert
Published: (2021-07-01)

A Novel Missense Mutation of the NSD1 Gene Associated with Overgrowth in Three Generations of an Italian Family: Case Report, Differential Diagnosis, and Review of Mutations of NSD1 Gene in Familial Sotos Syndrome
by: Gianluigi Laccetta, et al.
Published: (2017-11-01)

Investigation of NSD2 Protein Expression Changes in Hepatocellular Carcinoma Cells After Treatment With Curcumin and Phthalates
by: Seyed Ehsan Alavian, et al.
Published: (2023-09-01)

Investigation of NSD2 Protein Expression Changes in Hepatocellular Carcinoma Cells After Treatment With Curcumin and Phthalates
by: Seyed Ehsan Alavian, et al.
Published: (2023-01-01)

Comprehensive pan-cancer analysis identified NSD2 as a potential prognostic and diagnostic biomarker
by: Shuang Wang, et al.
Published: (2025-01-01)

NSD family proteins: Rising stars as therapeutic targets
by: Lin He, et al.
Published: (2024-04-01)

Clinical details of individuals with Rauch–Steindl syndrome due to NSD2 truncating variants
by: Eriko Nishi, et al.
Published: (2024-02-01)

Prospect of targeting lysine methyltransferase NSD3 for tumor therapy
by: Dan Li, et al.
Published: (2023-08-01)

A novel nonsense variant in NSD1 gene in a female child with Sotos syndrome: A case report and literature review
by: Xinting Liu, et al.
Published: (2023-12-01)

Identification of Novel NSD1 variations in four Pediatric cases with sotos Syndrome
by: Zhuo Ren, et al.
Published: (2024-04-01)

Clinical and Biological Characteristics of 14 Adult Cases of NUP98-NSD1+ Acute Myeloid Leukemia
by: Yan-jun Sun, et al.
Published: (2023-12-01)

Species-specific gene regulatory network rewiring mediated by the GATA-type regulator NsdD in Aspergillus
by: Heungyun Moon, et al.
Published: (2025-08-01)

Study on the regulatory mechanism of NsdAsr on rimocidin biosynthesis in Streptomyces rimosus M527
by: Yawen Xie, et al.
Published: (2025-07-01)

NSD2 and miRNAs as Key Regulators of Melanoma Response to Romidepsin and Interferon‐α2b Treatment
by: Alessandro De Santis, et al.
Published: (2025-05-01)

Epithelial NSD2 maintains FMO‐mediated taurine biosynthesis to prevent intestinal barrier disruption
by: Yue Xu, et al.
Published: (2024-12-01)

Epigenetic mechanisms of Nsd1-mediated histone methylation modifications in chondrocyte ferroptosis in knee osteoarthritis
by: Rao Wang, et al.
Published: (2024-08-01)

Identification of Novel Hits of the NSD1 SET Domain by NMR Fragment-Based Screening
by: TANG Heng, et al.
Published: (2019-06-01)

H3K36 methyltransferase NSD1 is essential for normal B1 and B2 cell development and germinal center formation
by: Sulan Zhai, et al.
Published: (2022-11-01)

Case report: A de novo NSD2 truncating variant in a child with Rauch-Steindl syndrome
by: Qi Yang, et al.
Published: (2023-06-01)

Knockout of the histone methyltransferase NSD1 leads to a decrease in cell proliferation and an increase in sensitivity to cisplatin in laryngeal squamous cell carcinoma
by: I. A. Topchu, et al.
Published: (2023-05-01)

In silico derived small molecules targeting the finger-finger interaction between the histone lysine methyltransferase NSD1 and Nizp1 repressor
by: Andrea Berardi, et al.
Published: (2020-01-01)

Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1
by: Li Liu, et al.
Published: (2024-07-01)

Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and in vitro and in vivo biological activity evaluations
by: Xing Jin, et al.
Published: (2024-12-01)

Loss of NSD2 causes dysregulation of synaptic genes and altered H3K36 dimethylation in mice
by: Shiori Kinoshita, et al.
Published: (2024-02-01)

From Wolf-Hirschhorn syndrome to NSD2 haploinsufficiency: a shifting paradigm through the description of a new case and a review of the literature
by: Luisa Cortellazzo Wiel, et al.
Published: (2022-05-01)

Conditional knockout of the NSD2 gene in mouse intestinal epithelial cells inhibits colorectal cancer progression
by: Mengyuan Li, et al.
Published: (2025-02-01)

NSD3::NUTM1 fusion evidenced on RNA sequencing in poorly differentiated thyroid cancer: a report of two cases
by: Renaud Ciappuccini, et al.
Published: (2025-10-01)

NSD3, a member of nuclear receptor‐binding SET domain family, is a potential prognostic biomarker for pancreatic cancer
by: Qunli Xiong, et al.
Published: (2023-05-01)

NUP98::NSD1 and FLT3/ITD co-expression is an independent predictor of poor prognosis in pediatric AML patients
by: Jing-wen Wang, et al.
Published: (2024-08-01)

Multilevel Regulation of NF‐κB Signaling by NSD2 Suppresses Kras‐Driven Pancreatic Tumorigenesis
by: Wenxin Feng, et al.
Published: (2024-08-01)

NSD1 stimulated survival and migration of gastric cancer cells through WNT10B
by: Bin Li, et al.
Published: (2021-07-01)

Sotos syndrome with marked overgrowth in three Japanese patients with heterozygous likely pathogenic NSD1 variants: case reports with review of literature
by: Yohei Masunaga, et al.
Published: (2024-01-01)

Identifying and ranking of Critical Success Factors (CSF) of Civic Services in New Service Development (NSD) Projects of Municipality by Use of Grey Relational Analysis (GRA) Technique Study
by: Seyed Habib Allah Mirghafoori
Published: (2012-11-01)

<i>NSD1</i> Mutations in Sotos Syndrome Induce Differential Expression of Long Noncoding RNAs, miR646 and Genes Controlling the G2/M Checkpoint
by: Giuseppina Conteduca, et al.
Published: (2022-07-01)

<i>NSD3::NUTM1</i> Fusion Sarcoma Mimicking Malignant Peripheral Nerve Sheath Tumor with Prolonged Survival
by: Jing Di, et al.
Published: (2024-08-01)